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There are a wide variety of reactive species which can affect cell function, including reactive
oxygen, nitrogen, and lipid species. Some are formed endogenously through enzymatic or
non-enzymatic pathways, and others are introduced through diet or environmental expo-
sure. Many of these reactive species can interact with biomolecules and can result in
oxidative post-translational modification of proteins. It is well documented that some oxida-
tive modifications cause macromolecular damage and cell death. However, a growing body
of evidence suggests that certain classes of reactive species initiate cell signaling by react-
ing with specific side chains of peptide residues without causing cell death.This process is
generally termed “redox signaling,” and its role in physiological and pathological processes
is a subject of active investigation. This review will give an overview of oxidative protein
modification as a mechanism of redox signaling, including types of reactive species and
how they modify proteins, examples of modified proteins, and a discussion about the
current concepts in this area.
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WHAT ARE REACTIVE SPECIES?
“Reactive species”is an umbrella term often used to describe a myr-
iad of small molecules which can participate in chemical reactions.
Reactive oxygen species (ROS) include superoxide
(
O•−2
)
, hydro-
gen peroxide (H2O2), hydroxyl radical (HO•), and other reactive
molecules containing oxygen (Finkel, 2011). Reactive nitrogen
species (RNS) are nitrogen-containing molecules including nitric
oxide (NO•) and higher oxides of NO• such as dinitrogen triox-
ide (N2O3), peroxynitrite (ONOO−), and nitroxyl anion (HNO−;
Hill et al., 2010). Reactive lipid species (RLS) are usually derived
from unsaturated lipids and include among others, lipid aldehy-
des (e.g., 4-hydroxynonenal) and reactive prostaglandins of the A-
and J-series (Higdon et al., 2012). While these terms cover a wide
variety of molecules, they are a convenient, though often vague,
way to describe the action of these types of compounds without
implying one specific mediator.
Reactive species can be derived exogenously from the diet and
environment as well as endogenously through enzymatic or non-
enzymatic processes. Exogenous sources of reactive species have
been shown to have both beneficial and harmful cellular effects,
Abbreviations: O•−2 , superoxide; 15d-PGJ2, 15-deoxy-∆12,14-prostaglandin J2; 4-
HNE, 4-hydroxynonenal; ARE/EpRE, antioxidant response element/electrophile
response element; BH4, tetrahydrobiopterin; CICR, Ca2+-induced Ca2+ release;
H2O2, hydrogen peroxide; HNO−, nitroxyl anion; HO•, hydroxyl radical; HO-
1, heme oxygenase-1; Keap1; iNrf2, Kelch-like ECH-associated protein 1; N2O3,
dinitrogen trioxide; NO•, nitric oxide; NOS, nitric oxide synthase; ONOO−, per-
oxynitrite; PGA1, prostaglandin A1; PGD2, prostaglandin D2; PGIS, prostaglandin
I2 synthase; Prx, peroxiredoxin; RLS, reactive lipid species; RNS, reactive nitro-
gen species; ROS, reactive oxygen species; RyR2, ryanodine receptor 2; SNAP,
S-nitroso-N -acetyl penicillamine.
since they may either participate in cell signaling or may cause
macromolecular damage. For example, dietary compounds such
as curcumin in curry, and sulforaphane in cruciferous vegetables
(e.g., brussel sprouts) are electrophilic and reactive with pro-
tein thiols (Brennan and O’Neill, 1998; Hong et al., 2005). These
compounds have been shown to have potent anti-inflammatory
properties and potential health benefits (Clarke et al., 2008;
Lopez-Lazaro, 2008; Zhao et al., 2011). Other bioactive dietary
components such as quercetin which is abundant in fruits, and
phytoprostanes in fresh vegetable oils have been shown to be
metabolized within the cell to reactive species which are anti-
inflammatory (Spencer et al., 2003; Karg et al., 2007). On the
other hand, compounds such as acrolein in cigarette smoke and
acrylamide in fried foods are associated with predominantly dele-
terious effects such as depletion of cellular glutathione and neu-
rotoxicity (LoPachin and Barber, 2006; Stevens and Maier, 2008).
In addition, there are endogenous sources of reactive species
that have specific roles in physiology. For example, nitric oxide
synthase (NOS) produces NO• in a controlled manner to regulate
the physiological processes of vasodilation (Gruetter et al., 1979),
modulation of mitochondrial respiration (Brookes et al., 2002),
and immunodefense (Sakiniene et al., 1997). The overall effect of
NO• is determined by the amount of NO• produced and the site of
production. Low levels of NO•, produced by the endothelial iso-
form of NOS (eNOS), diffuse to adjacent vascular smooth muscle
cells to mediate vasodilation. However, high levels of NO• pro-
duced by the inducible NOS isoform (iNOS) during inflammation
may cause cell death by inhibition of mitochondrial respiration
and other mechanisms (Brown and Borutaite, 2002). Other enzy-
matic sources of reactive species include xanthine oxidase and
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NADPH oxidases. Additionally, electrons from the mitochondrial
respiratory chain can univalently reduce oxygen to generate O•−2
(Thannickal and Fanburg, 2000).
Some of the earliest studies in reactive species have centered
on O•−2 , H2O2, NO•, ONOO−. H2O2, in particular, is a potent
mediator of signal transduction and can mediate oxidation of
protein thiols (Rhee et al., 2003). The cellular actions of H2O2
are primarily dependent upon the location of production, the
concentration of H2O2, and presence of H2O2 metabolizing pro-
teins (e.g., catalase, peroxiredoxin, glutathione peroxidase, etc.).
The expression of H2O2 metabolizing proteins is highly regu-
lated with specific isoforms often localized to particular sub-
cellular organelles. Endogenous production of oxidants such as
hypochlorous acid (HOCl) and hypobromous acid (HOBr) have
also been demonstrated, and their importance in physiology and
pathology is becoming more widely recognized since these com-
pounds are thought to play an important role in the antimicrobial
response of host immune cells during infection (Weiss et al., 1986;
Hurst and Barrette, 1989; Carr et al., 1998).
More recently, the endogenous generation of RLS is emerg-
ing an important mechanism of cellular signaling, particularly
with respect to inhibiting inflammation, or at higher levels medi-
ating apoptosis. RLS can be derived from oxidation of n-3 or
n-6 polyunsaturated lipids which are cleaved from the membrane
prior to oxidation. Alternatively, lipids may be oxidized within
the membrane giving rise to hydroxy-alkenals and oxidized phos-
pholipids which are active in physiological and/or pathological
conditions (Kadl et al., 2004; Catala, 2009). Oxidized lipids can be
formed enzymatically (e.g., lipoxygenase, cyclooxygenase), or non-
enzymatically via lipid peroxidation or nitration pathways. There
are a large number of unique RLS, however, these can typically be
grouped according to which functional groups are present. Major
classes of reactive lipids include lipid aldehydes, α,β-unsaturated
carbonyls, and nitroalkenes [see (Higdon et al., 2012)]. In most
cases, reactive lipids are electrophilic and can react with cellular
nucleophiles which include certain amino acid side chains. Some
reactive lipids contain more than one functional group, which
is the case with 4-hydroxynonenal (4-HNE). 4-HNE can partici-
pate in Schiff base reactions involving the aldehyde group, and/or
Michael addition reactions involving the electrophilic β-carbon
[see (Higdon et al., 2012)].
REDOX SIGNALING OR OXIDATIVE DAMAGE?
At the cellular level, the effects of reactive species can range from
cell death due to widespread damage to macromolecules to more
subtle effects on cell metabolism, morphology, or signaling path-
ways (Martindale and Holbrook, 2002). The overall impact of a
reactive species on cellular function varies with reactive species,
but can also be affected by cell type, levels of endogenous antioxi-
dants and antioxidant enzymes, differentiation state, extracellular
environment, and many other factors (Jones and Go, 2010). Gen-
erally, severe oxidative stresses occur during exposure of cells to
radiation, occupational exposures to highly reactive chemicals
such as paraquat, and during pathology (Shacter, 2000). In these
cases, reactive species can cause DNA base modification, phospho-
lipid damage, and irreversible protein oxidation which can lead to
cell death or mutagenesis. However, mild to moderate oxidative
stresses occur during normal physiology, exercise, or growth. The
reactive species generated during these types of stresses lead to cel-
lular protection, improved metabolism, and resistance to oxidative
damage (Higdon et al., 2012).
The difference between cellular signaling and damage by reac-
tive species are governed by a number of properties inherent to the
reactive species. Generally, the relative reactivity and specificity are
two major properties dictating how reactive species will interact
with targets. For the purpose of this review, the term “reactivity”
is used to describe the ability and the rate at which reactive species
can chemically react with a target. Highly reactive species, such
as hydroxyl and alkoxyl radicals, have relatively high reaction rate
constants, which in the case of hydroxyl radical is close to the
diffusion limit, and therefore will react with and modify targets
which are closest to the site of production of these species with
little to no specificity (Sies, 1993). Reactivity is derived from the
chemical properties of both the reactive species and the target.
The term “specificity” refers to the ability of reactive species to
make adducts with one class of molecules preferably over another.
Reactivity and specificity have an inverse relationship in that, gen-
erally, reactive species which are more reactive are also less specific.
Thus, highly reactive species usually cannot achieve specificity. The
relationship between the reactivity and specificity of selected elec-
trophilic lipid species (electrophiles) is used as an example of this
relationship in Figure 1. The electrophiles are listed in relative
order of reactivity with those on the left having the lowest reac-
tivity and those on the right having the highest (LoPachin et al.,
2007). Those reactive electrophiles found on the right of the dia-
gram exhibit less specificity in reactions with nucleophilic targets
than those on the left. Importantly, highly reactive compounds are
also associated with macromolecular damage and tend to form
adducts with protein targets which are relatively abundant, since
the probability of a reaction with these proteins is higher. Con-
versely, reactive species with lower reactivity, as exemplified by the
compounds on the left side of Figure 1, exhibit more specificity,
resulting in the formation of adducts with certain protein residues
(e.g., cysteine). As opposed to the highly reactive compounds, these
FIGURE 1 | Reactivity versus specificity. The compounds shown are
electrophilic and have a very wide spectrum of reactivity. They are listed in
order of increasing reactivity from left to right. The relative reactivity is
predicted based on previously published reaction rate constants and
electrophilicity indexes [see (LoPachin et al., 2007; Rudolph and Freeman,
2009)]. Reactivity is inversely correlated with their specificity in that those
on the left are more specific for Cys, which is the most reactive nucleophilic
residue in the cell. On the structures listed, the asterisk denotes the
electrophilic atom(s) of the compound.
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less reactive electrophiles are usually associated with signaling and
the modification of a relatively small subset of proteins which is
not solely dependent on the abundance of the target and more
dependent on the specificity toward a target. We have previously
shown that an electrophilic lipid with low reactivity at sublethal
doses forms adducts with primarily cysteine residues and alters cell
signaling (Levonen et al., 2004; Diers et al., 2010a). Thus, demon-
strating that reactive species having low reactivity are more likely
to participate in cell signaling than damage (Levonen et al., 2004;
Diers et al., 2010a). This concept is also applicable to the reactivity
of reactive oxygen and nitrogen species and the relative reactiv-
ity of these compounds is reviewed elsewhere (D’Autreaux and
Toledano, 2007; Toledo and Augusto, 2012). However, it is impor-
tant to note that even highly reactive species at low levels may
be able to mediate cell signaling, and reactive species with lower
reactivity can be damaging at high levels.
Beyond reactivity and specificity, other important factors are
involved in determining how reactive species cause specific cellular
effects. These include, but are not limited to: (1) site of production,
(2) localization, and (3) reactivity of the target. The site of pro-
duction of the reactive mediator is important with highly reactive
species which have limited diffusion distances since these mole-
cules cannot mediate downstream signaling unless the target is
nearby (Forman et al., 2004; Pacher et al., 2007). The site of pro-
duction may also allow for the accumulation of a reactive species,
thereby resulting in locally elevated concentrations necessary for
signaling. Also, the site of production of those reactive species
which are more reactive and therefore less specific is important for
dictating a response. Some enzymes produce reactive species in a
localized region, such as membrane lipid rafts (Chen et al., 2009).
For example, there is evidence that an isoform of the enzyme
NADPH oxidase which produces superoxide is located at special-
ized lipid rafts with other proteins sensitive to superoxide (Jin
et al., 2011), thus creating a redox signaling hub. For this reason,
it may be speculated that for a reactive species (especially in the
case of highly reactive species) to produce a signaling effect, it
must either be produced or localized to the “correct” location in
order to elicit a specific response. The understanding of location
of production of reactive species will most definitely become an
increasingly important area of future studies.
Some reactive species are stable enough to diffuse away from
the site of production. For example, hydrogen peroxide is relatively
stable and can diffuse away from the site of production before
reacting (Winterbourn, 2008). Other reactive species such as the
electrophilic lipid, 15-deoxy-∆12,14-prostaglandin J2 (15d-PGJ2)
are very stable, and can diffuse between cells within a tissue to
mediate the resolution of inflammation (Gilroy et al., 1999). 15d-
PGJ2 has also been shown to localize to the mitochondrion based
on mitochondrial membrane potential (Landar et al., 2006). The
reason for this localization is not clear, however, a structurally sim-
ilar prostaglandin, PGE2, which is not reactive does not localize to
the mitochondrion, suggesting that the localization is dependent
on the electrophilic nature of the molecule (Landar et al., 2006).
Interestingly, the effects of 15d-PGJ2 within the mitochondrion
may be further enhanced by directing the molecule to the desired
compartment using molecular targeting strategies. For example,
15d-PGJ2 can exhibit protective effects against oxidative stress,
however, when this molecule is directed to the mitochondrion
by conjugation to a lipophilic cation, its apoptotic signaling is
enhanced (Diers et al., 2010b). Since adducts can accumulate
over time, the actions of signaling molecules such as 15d-PGJ2,
which function via oxidative post-translational modifications, are
determined by the relative rate of production of the species versus
the rate of adduct turnover by the cell (Oh et al., 2008).
Lastly, it is worth mentioning that the reactivity of the target
is important in determining the effects of a reactive species. It is
well-established that some reactive species can react with and dam-
age DNA by chemically adducting to specific bases (LoPachin and
Decaprio, 2005). The next section will focus on some of the specific
properties of the nucleophilic protein targets. Therefore, for the
purpose of this review, we will focus on oxidative modifications
of protein residues by low to moderate levels of reactive species
which are commonly encountered in pathology and physiology.
EXAMPLES OF OXIDATIVE POST-TRANSLATIONAL
MODIFICATION OF PROTEINS
It is becoming widely appreciated that reactive species produced in
a controlled manner can covalently adduct to specific amino acids
in order to elicit a cellular effect. The most commonly studied
amino acids modified by reactive species are tyrosine and cysteine.
The endogenous modification of tyrosine by reactive species in
biological systems has been a subject of interest since the discovery
of protein nitrotyrosine modifications in human atherosclerosis
(Beckmann et al., 1994). Most reports on nitrotyrosine involve
the use of this modification as a marker of peroxynitrite or other
RNS formation, and suggest that this modification is deleterious.
In fact, nitrotyrosine has been associated with the development of
a number of pathologies including heart failure, atherosclerosis,
aging,and hypertension [for review see (Pacher et al.,2007)]. How-
ever, nitrotyrosine may also be involved in physiological processes
(Pacher et al., 2007). Whether tyrosine nitration is a normal mech-
anism of redox signaling or a marker of protein damage is currently
an area of active investigation, but there is some evidence that low
levels of peroxynitrite may cause modification of specific tyro-
sine residues which demonstrates that not all tyrosyl residues are
equally susceptible to modification (Schmidt et al., 2003).
Perhaps, the most well characterized residue involved in redox
signaling is cysteine. Cysteine accounts for an estimated 1.9% of
residues within proteins, and a small number of these cysteines are
known to participate in redox signaling (Go et al., 2011). The thiol
group (-SH) on the side chain of cysteine can act as a switch for
redox signaling and homeostasis. Because the sulfur atom has mul-
tiple oxidation states, the side chain of cysteine is readily oxidized
to various products, some of which have specialized functions
(Jacob et al., 2003). The protonated form of the thiol group (-SH)
is not particularly reactive, but the deprotonated form (-S−), or
thiolate anion, is nucleophilic since it is rich in available electrons
(LoPachin et al., 2007). For this reason, not all cysteines have thiols
which are equally intrinsically reactive. This inherent reactivity is
dictated by a number of contributing factors including accessibil-
ity and acid dissociation constant (pKa) of the thiol group. The
pKa of a thiol is defined as the pH at which 50% of that thiol is in
the deprotonated state. Thus, as shown in Figure 2, at physiologi-
cal pH (7.4) the reactivity of the thiol can vary widely depending
on the pKa of the thiol. Thiols which have a relatively low pKa
tend to exist in the depronated thiolate anion form, and are thus
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FIGURE 2 | Relationship of thiol pKa and reactivity. The acid dissociation
constant (pKa) of a thiol group determines the ratio of thiol:thiolate at a
given pH. This value varies for each cysteinyl thiol and is influenced by the
local protein environment. At a physiological pH of 7.4, the relative
percentages of protonated thiol and deprotonated thiolate anion are listed
for cysteine residues which have different pKas of 6.4, 7.4, or 8.4. The thiol
with a pKa of 6.4 is expected to be nearly 90% in the thiolate form at pH 7.4,
and is therefore more reactive than thiols with higher pKa values.
more likely to be modified by a reactive species. For this reason,
the pKa is important in determining the specificity of cysteine
modifications by reactive species such as hydrogen peroxide and
electrophiles (Rhee et al., 2003; Martyniuk et al., 2011). The thio-
late group can participate in reactions with electrophilic reactive
species either via nucleophilic substitution reactions or by Michael
addition to form covalent adducts. There is also evidence demon-
strating site-selective modification of cysteine residues within a
single protein by different reactive species (Renedo et al., 2007;
Jones, 2010) though characterization of this type of regulation
for a broad range of proteins and reactive species has not been
reported to date.
The next sections will highlight some specific examples of reac-
tive species modifications organized by type of modification and
the functional consequences for each example will be discussed.
TYROSINE NITRATION OF PROSTACYCLIN SYNTHASE
Protein tyrosine nitration occurs with the addition of an NO2
group to the ortho position of the aromatic ring of tyrosine.
Tyrosine residues have been shown to be nitrated by at least two
multistep mechanisms involving RNS. One pathway involves the
formation of a tyrosyl radical which then reacts with a peroxyni-
trite radical breakdown product, NO•2, to produce 3-nitrotyrosine
(for reviews see (Pacher et al., 2007; Peluffo and Radi, 2007). Per-
oxynitrite is a potent oxidant formed by the reaction of superoxide
anion with NO• and is produced during inflammatory processes.
Interestingly, the main source of superoxide production in the vas-
culature during inflammation is from NOS itself. During inflam-
mation, the tetrahydrobiopterin (BH4) cofactor within the NOS
enzyme can become oxidized, thereby uncoupling the enzyme
and allowing electrons to reduce molecular oxygen to superox-
ide. Thus, NOS produces less NO•, and ultimately decreases NO•
bioavailability (Alp and Channon, 2004). Tyrosine nitration has
been of interest during conditions of inflammation by changing
the function of target proteins.
Prostaglandin I2 synthase (PGIS) is one example of a protein
which is modified by tyrosine nitration. PGIS is a heme-containing
protein which catalyzes the rearrangement of prostaglandin H2 to
prostaglandin I2 (or prostacyclin). PGIS, also known as CYP8A1,
is a member of the cytochrome P450 superfamily and controls
vascular tone by regulating the production of prostacyclin in the
vasculature. Because prostacyclin is a potent vasodilator, PGIS
activity has been shown to play an important role in vascular
protection (Wu and Liou, 2005). During times of chronic inflam-
mation and subsequent production of peroxynitrite, the tyrosine
residue of PGIS, Tyr430, is nitrated resulting in a decrease in
PGIS catalytic activity. This tyrosine nitration, in turn, inhibits
prostacyclin-dependent relaxation [for review, see (Zou, 2007)].
Moreover, formation of peroxynitrite also decreases the bioavail-
ability of NO•, a key vasodilator, and further promotes vasocon-
striction. Though the effects are usually deleterious to vascular
function, PGIS represents an example of a protein which is mod-
ified by low levels of a reactive species, peroxynitrite (Zou et al.,
1999).
CYSTEINE OXIDATION OF PEROXIREDOXIN
Oxidation of cysteines is another widely recognized mechanism
of redox signaling (Forman et al., 2004; Winterbourn and Hamp-
ton, 2008; Paulsen and Carroll, 2010; Finkel, 2011). Disulfide bond
formation has long been known to be important in protein struc-
ture and function (Tu and Weissman, 2004), and more recently
its role in redox signaling has been demonstrated (Frand et al.,
2000; Jones et al., 2004). Currently, there is an interest in oxida-
tion of thiols which results in the addition of oxygen(s) to the
sulfur group of the amino acid cysteine. The reaction of hydrogen
peroxide (H2O2) with the deprotonated cysteinyl thiol of proteins
produces an oxidized thiol or sulfenic acid (R-SOH; Poole et al.,
2004). A sulfenic acid may be oxidized again to yield a hyperox-
idized sulfinic acid cysteine (R-SO2H). With increasing levels of
reactive species, cysteines can further be oxidized to a sulfonic acid
(R-SO3H; Poole et al., 2004). While sulfenic acids are enzymati-
cally reversible by the glutathione and thioredoxin enzyme systems
(Berndt et al., 2007), the sulfinic state can only be reversed enzy-
matically in certain proteins. Sulfonic acid modification is thought
to be irreversible and may represent protein damage, rather than
signaling.
An example of thiol oxidation is found in the peroxiredoxin
(Prx) family of enzymes (Stacey et al., 2012). These proteins con-
tain a reactive cysteinyl thiol in the active site, and the formation
of sulfenic acid occurs in their normal catalytic cycle (Rhee et al.,
1999, 2005; Stacey et al., 2012). Prxs have the capacity to protect
proteins from oxidative damage induced by hydrogen peroxide in
a thiol dependent manner. Two cysteine residues, corresponding
to Cys47 and Cys170 of yeast Prx are highly conserved. In the
presence of hydrogen peroxide, Cys47 gets oxidized to the sulfenic
acid intermediate (Cys–SOH). Cys170 is responsible for forming
a disulfide linkage with Cys47 (Cys47–S-S–Cys170) in order to
resolve the sulfenic acid (Chae et al., 1994). Through a disulfide
switching mechanism, the enzyme thioredoxin completes the cat-
alytic cycle by reducing the disulfide bond between Cys47 and
Cys170. In addition to H2O2, Prx directly reduces peroxynitrite
and lipid peroxides (Bryk et al., 2000). Importantly, Prx can be
hyperoxidized in the presence of excess hydrogen peroxide to the
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sulfinic acid form which inactivates its function. Sulfinic acid for-
mation in many proteins is not reversible, but sulfinic acid in Prx
has been shown to be reduced by a unique thiol dependent enzyme,
sulfiredoxin (Chang et al., 2004). Thus, Prx plays a crucial role in
redox signaling since it regulates peroxide levels, but in turn is
regulated by peroxide itself (Rhee et al., 2012).
S -NITROSATION OF RYANODINE RECEPTOR 2
S-Nitrosation is the post-translational modification of a thiol
group to form an S-nitrosothiol which has the general structure
of R-S-N=O (Zhang and Hogg, 2005). While the mechanism
for RSNO formation in biological systems remains poorly under-
stood, RSNOs are thought to be downstream mediators of nitric
oxide signaling. Because of the critical role of nitric oxide in
cardiovascular (patho)physiology, much interest has focused on
S-nitrosation of proteins involved in excitation-contraction cou-
pling in the heart (Gonzalez et al., 2009). In the beating heart,
membrane depolarization causes the opening of L-type voltage-
gated channels in the plasma membrane and calcium (Ca2+) influx
into cardiac myocytes. This Ca2+ influx then triggers the release
of Ca2+ from the sarcoplasmic reticulum through the opening of
ryanodine receptors, a process termed Ca2+-induced Ca2+ release
(CICR; Fabiato, 1983). Ryanodine receptors as well as other chan-
nels involved in CICR (e.g., voltage-gated sodium and potassium
channels) have been shown to be targets of S-nitrosation (Gonza-
lez et al., 2009). However, here, we will discuss in detail only the
modification of ryanodine receptors.
Ryanodine receptor 2 (RyR2) is the isoform expressed in the
heart. The early observation that treatment of RyR2 in recon-
stituted lipid bilayers with agents which initiate S-nitrosation
(e.g., S-nitroso-N -acetyl penicillamine; SNAP) increased the open
probability (PO) of the channel provided one of the first links
between nitric oxide signaling and Ca2+ handling at the level
of sarcoplasmic reticulum. Moreover, this effect was reversed
with the addition of thiol reducing agents, further implicating
reversible post-translational modification as a mechanism for reg-
ulation of RyR2 (Stoyanovsky et al., 1997). RyR2 has 89 cysteine
residues per monomeric subunit, and approximately 21 of these
are thought to exist as free thiols. Modification of multiple cysteine
residues is required for full activation of RyR2 by S-nitrosation (Xu
et al., 1998). Cardiac ryanodine receptors have also been shown
to be constitutively S-nitrosated in vivo (Sun et al., 2008), and
changes in the redox state of RyR2 thiols have been observed
in cardiac pathologies (Yano et al., 2005; Terentyev et al., 2008).
Examination of ryanodine receptors isolated from canine heart
and rabbit skeletal muscle show that these proteins are suscepti-
ble to multiple oxidative modifications including S-nitrosation,
S-gluthionylation, and oxidation to form disulfide bonds, and
more recent studies demonstrate that ryanodine receptors co-
immunoprecipitate with NOS enzymes, implying that ryanodine
receptors are spatially linked to an endogenous source of nitric
oxide (Barouch et al., 2002; Martinez-Moreno et al., 2005). Taken
together, these studies specifically highlight the important role of
S-nitrosation in mediating downstream nitric oxide-dependent
effects on Ca2+ handling in the heart and, more generally, point
to a mechanism by which nitric oxide regulates cellular events
beyond its canonical role in cGMP-dependent responses.
ELECTROPHILIC LIPID MODIFICATION OF KEAP1
The covalent modification of thiol groups of cysteine residues by
electrophiles is another example of an oxidative post-translational
modification which results in redox signaling (Higdon et al., 2012).
Depending on the type of electrophile, adducts may be formed
with nucleophilic cysteinyl thiols through Michael addition or
through a nucleophilic substitution (SN2) reaction (Hill et al.,
2009). Michael addition involves the formation of an adduct which
is equal to the exact mass of the electrophile and nucleophile.
Nucleophilic substitution results in the formation of an adduct
and a leaving group, such as an iodide or chloride moiety from the
electrophile. Cyclopentenone prostaglandins, such as 15d-PGJ2,
are electrophilic lipids which contain an α,β-unsaturated carbonyl
group (Figure 3A, right hand panel). During adduct formation,
the lipid forms a covalent adduct by Michael addition of the elec-
trophilic carbon with the cysteinyl thiol group of the protein. In the
case of 15d-PGJ2, there are actually two β-carbons which are elec-
trophilic (Figure 3A right hand panel, denoted by asterisks) due to
the presence of two double bonds flanking the carbonyl. However,
the β-carbon within the cyclopentenone ring is most commonly
found to form adducts with proteins (Uchida and Shibata, 2008).
Interestingly, it has been reported that the modification of thiols
by electrophilic compounds can be exquisitely site-specific, since
different thiols within a single protein can be modified by dif-
ferent cyclopentenone prostaglandins (Gayarre et al., 2005). One
well characterized protein modified by electrophilic lipids is the
Kelch-like ECH-associated protein 1 (Keap1; Itoh et al., 2004; Lev-
onen et al., 2004), which is involved in the redox regulation of
transcription (Brigelius-Flohe and Flohe, 2011).
Keap1 (also known as iNrf2) is normally found in the cellular
cytoplasm complexed with the transcription factor Nrf2 (Kaspar
et al., 2009). The interaction of Keap1 with Nrf2 under basal con-
ditions directs Nrf2 for degradation by the ubiquitin-proteasomal
system (McMahon et al., 2003; Kobayashi et al., 2004). Keap1 cys-
teine residues,Cys273 and Cys288, have been shown to be modified
by 15d-PGJ2 thereby preventing proteasomal degradation of Nrf2
(Levonen et al., 2004; Yamamoto et al., 2008). Thus, modifica-
tion of Keap1 allows for accumulation of Nrf2 and promotes its
subsequent translocation to the nucleus (Kobayashi et al., 2006)
where Nrf2 regulates the transcription of a number of proteins
under the control of the antioxidant response element/electrophile
response element (ARE/EpRE) such as glutathione synthase and
heme oxygenase-1 (HO-1; Levonen et al., 2004; Wakabayashi et al.,
2004). In this way, Keap1 is thought to play a critical role in the
cellular response to electrophiles (Dinkova-Kostova et al., 2005).
Moreover, activation of Nrf2 by electrophiles through this mech-
anism and the resulting ARE/EpRE-dependent gene transcription
has a major impact on the resolution of inflammation (Levonen
et al., 2004).
COVALENT MODIFICATION AS A MECHANISM OF CELL
SIGNALING
As illustrated above, the modification of specific amino acids
by reactive species can elicit changes in protein function and
thereby mediate redox signaling. Covalent redox signaling differs
from classical receptor-ligand mediated signaling in several criti-
cal ways. This can be illustrated by comparing structurally related
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FIGURE 3 | Comparison of non-covalent and covalent signaling
molecules. (A) The structures of two prostaglandins, PGD2 (left
structure) and 15d-PGJ2 (right structure), are shown. Electrophilic
carbons which arise from presence of α, β-unsaturated carbonyl
functional groups are denoted by asterisks, and α- and β-carbons are
indicated. (B) Left hand panel: in the non-covalent or classical
receptor-ligand model (left hand panel), the ligand PGD2 is recognized
by a specific receptor on the cell membrane. The binding event
causes the activation of a signaling cascade which ultimately changes
cellular function. Right hand panel: in the covalent signaling model, a
reactive species 15d-PGJ2 directly forms a covalent adduct with
select proteins, in this case, the cytosolic repressor protein Keap1.
This binding event causes changes in endogenous antioxidant protein
transcription via the transcription factor Nrf2.
endogenous lipids: the non-electrophilic prostaglandin PGD2 and
the electrophilic prostaglandin 15d-PGJ2 (Figure 3B). As a classic
receptor-mediated ligand, PGD2 binds reversibly to a G-protein
coupled receptor and initiates a signaling cascade. In contrast,
15d-PGJ2 forms a covalent adduct with its target protein(s) which
results in a specific downstream effect (as described above for its
effects on the Keap1/Nrf2 system; Figure 3B). The signaling of
PGD2 and 15d-PGJ2, both are dependent on the amount of ligand
bound to the “receptor” in order to initiate a signaling cascade. For
a non-covalent ligand, such as PGD2, this is determined by the con-
centration of ligand present at a given time. However, due to the
ability for 15d-PGJ2 to covalently modify its “receptor(s),” adducts
may accumulate over time, even at low concentrations of the lig-
and. Thus, the steady-state concentration of 15d-PGJ2 and similar
covalent ligands is not necessarily the primary determinant of sig-
naling, but rather the absolute amount of the ligand present over
time. For example, we have observed that exposure of endothelial
cells in vitro to low amounts of a reactive species over a longer
period of time will lead to the gradual accumulation of adducts
and a level of signaling comparable to an exposure to a higher
bolus dose for a shorter period of time (Oh et al., 2008). In this
experiment, 20 additions of 0.1 nmol 15d-PGJ2 over 7 h resulted
in similar induction of HO-1 and GSH as a bolus dose of 2 nmol
lipid at t= 0 h in endothelial cells. Thus, covalent redox signaling
molecules may result in sustained signaling at very low levels, and
do not need to achieve high concentrations in order to be effica-
cious. We are only now beginning to appreciate the importance
of treatment conditions when comparing reactive species across
studies.
DISCUSSION OF THE POTENTIAL FOR COORDINATED
CHANGES IN CELLULAR FUNCTION
Another notable characteristic of covalent redox signaling is that,
because there is specificity for which proteins are modified, there
is often a relatively small group of proteins which are modified
simultaneously. Therefore, the downstream effect is likely to be a
summation of the effects of the modification of targeted proteins.
In addition, covalent redox signaling pathways have been shown to
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cross-talk with other signaling pathways, such as phosphorylation
cascades and calcium mobilization (Diers et al., 2010a; Klomsiri
et al., 2011). Thus, the overall activity of a redox signaling pathway
will be dependent on which proteins are specifically modified and
the interaction of their coordinated effects.
Our understanding of how reactive species can modulate differ-
ent cell functions has been significantly strengthened through the
use of biotin-tagged electrophilic lipids (e.g., biotin-15d-PGJ2)
to evaluate cell function while concomitantly tracking its pro-
tein adducts. 15d-PGJ2 is particularly interesting since it has been
shown to affect cellular functions through pleiotropic mechanisms
(Straus and Glass, 2001; Pignatelli et al., 2005). Our studies have
shown that 15d-PGJ2 reacts with a small group of proteins at low
levels, and that with increasing exposure, the number of modi-
fied proteins and extent of modification also increases (Oh et al.,
2008). This is conceptually illustrated in Figure 4 by a general dose-
response of 15d-PGJ2 on known cellular effects. The cellular effects
which we have observed at relatively low, non-toxic levels include
inhibition of migration and cytoskeletal alterations (Diers et al.,
2010a). With progressively increasing levels of 15d-PGJ2 modifi-
cation, up-regulation of HO-1 was observed due to the activation
of Keap1/Nrf2 pathway, followed by cell death at the highest levels
of lipid (Ricart et al., 2009). Interestingly, at the highest levels of
15d-PGJ2, HO-1 levels decrease though Keap1 is modified (Ricart
et al., 2009), and the reason for this effect remains to be eluci-
dated. However, it is clear that the overall cellular response cannot
be explained by the modification of one target protein alone, and
is likely due to the modification of multiple proteins. Importantly,
the concepts discussed regarding 15d-PGJ2 should be applicable to
other reactive species which may have signaling roles. Importantly,
these concepts of redox signaling by reactive lipid, oxygen, and
nitrogen species apply to all cell types, but may vary from one cell
type to another based on the differences in protein composition
and antioxidant pathways specific to that cell type. Appreciating
the complexity of these redox signaling systems and understand-
ing how these pathways are dysfunctional during pathology is of
utmost importance to this growing field.
CONCLUSION
As more is learned about oxidative post-translational modifica-
tions and redox signaling, we will be able to better piece together
ways in which individually targeted modifications form protein
networks and orchestrate cellular responses. This will obviously
FIGURE 4 | Model of coordinated cellular effects in response to
electrophilic protein modification. The overall cellular effects of an
electrophile are dependent on the susceptibility of different target proteins
to be modified by that electrophile. With low levels of electrophile exposure,
post-translational modification of the most sensitive target will elicit a
cellular response “A.” With moderate electrophile exposure, modification of
(an) additional target(s) will result in cellular response “B.” Since response A
is still present in this example, the combination of responses A and B cause
a coordinated change in cell function by the same electrophilic mediator.
With relatively high electrophile exposure, modification of a less sensitive
target protein will elicit a new cellular response “C.” Since response A
remains and response B is downregulated, the coordinated change in cell
function is distinct from that observed at moderate electrophile doses.
be difficult to study experimentally, but is nevertheless important
to understand how a given reactive species may have pleiotropic
mechanisms and seemingly incongruent effects on cells, ranging
from protection against cell death to induction of apoptosis. There
is an urgent need for research strategies which take into account
systems biology and embrace the complexity of multiple pathways
in order to advance new breakthroughs for drug development.
In this vein, the inherent properties of a reactive species can be
used to direct the covalent modification of a group of proteins in
order to elicit specific cellular responses. In this way, novel redox
therapeutics can be designed to generate a sustained and defined
cellular effect in a variety of pathological conditions.
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